Determining the clinical epidemiology profile of Rheumatoid Arthritis and cost burden of hospital care in Western Australia (1980- 2015)

Khalid Almutairi

doi:10.26182/ffr0-m264

Determining the clinical epidemiology profile of Rheumatoid Arthritis and cost burden of hospital care in Western Australia (1980- 2015)

Khalid Almutairi

UWA Medical School

Research output: Thesis › Doctoral Thesis

127 Downloads (Pure)

Abstract

Rheumatoid arthritis (RA) is a heterogeneous disease with a substantial burden for patients, families, and the healthcare system. Australia seemed to have the highest RA prevalence and severity is essential to plan prevention, treatment, and management strategies. The WA Rheumatic Disease Epidemiological Registry was used to investigate the clinical epidemiology of RA in WA. The thesis concluded that RA prevalence in WA was 0.34%?0.36%, and demonstrated a decline in RA hospitalisations, comorbidity, and mortality but an increase in biological therapy utilitsation costs.

Original language	English
Qualification	Doctor of Philosophy
Awarding Institution	The University of Western Australia
Supervisors/Advisors	Inderjeeth, Charles, Supervisor Nossent, Hans, Supervisor Preen, David, Supervisor Keen, Helen, Supervisor
Thesis sponsors	Australian Government Research Training Program
Award date	19 May 2022
DOIs	https://doi.org/10.26182/ffr0-m264
Publication status	Unpublished - 2021

Access to Document

10.26182/ffr0-m264

THESIS - DOCTOR OF PHILOSOPHY - ALMUTAIRI, Khalid Bander D - 2022
This work is protected by Copyright. You may print or download ONE copy of this document for the purpose of your own non-commercial research or study. Any other use requires permission from the copyright owner. The Copyright Act requires you to attribute any copyright works you quote or paraphrase.

Cite this

@phdthesis{abbd402750394e04b76aa790953abcbb,

title = "Determining the clinical epidemiology profile of Rheumatoid Arthritis and cost burden of hospital care in Western Australia (1980- 2015)",

abstract = "Rheumatoid arthritis (RA) is a heterogeneous disease with a substantial burden for patients, families, and the healthcare system. Australia seemed to have the highest RA prevalence and severity is essential to plan prevention, treatment, and management strategies. The WA Rheumatic Disease Epidemiological Registry was used to investigate the clinical epidemiology of RA in WA. The thesis concluded that RA prevalence in WA was 0.34%?0.36%, and demonstrated a decline in RA hospitalisations, comorbidity, and mortality but an increase in biological therapy utilitsation costs.",

keywords = "Prevalence, Rheumatoid Arthritis, Linked data, Mortality, comorbidity, Biological therapy, Hospital admissions, burden",

author = "Khalid Almutairi",

year = "2021",

doi = "10.26182/ffr0-m264",

language = "English",

school = "The University of Western Australia",

}

TY - BOOK

T1 - Determining the clinical epidemiology profile of Rheumatoid Arthritis and cost burden of hospital care in Western Australia (1980- 2015)

AU - Almutairi, Khalid

PY - 2021

Y1 - 2021

N2 - Rheumatoid arthritis (RA) is a heterogeneous disease with a substantial burden for patients, families, and the healthcare system. Australia seemed to have the highest RA prevalence and severity is essential to plan prevention, treatment, and management strategies. The WA Rheumatic Disease Epidemiological Registry was used to investigate the clinical epidemiology of RA in WA. The thesis concluded that RA prevalence in WA was 0.34%?0.36%, and demonstrated a decline in RA hospitalisations, comorbidity, and mortality but an increase in biological therapy utilitsation costs.

AB - Rheumatoid arthritis (RA) is a heterogeneous disease with a substantial burden for patients, families, and the healthcare system. Australia seemed to have the highest RA prevalence and severity is essential to plan prevention, treatment, and management strategies. The WA Rheumatic Disease Epidemiological Registry was used to investigate the clinical epidemiology of RA in WA. The thesis concluded that RA prevalence in WA was 0.34%?0.36%, and demonstrated a decline in RA hospitalisations, comorbidity, and mortality but an increase in biological therapy utilitsation costs.

KW - Prevalence

KW - Rheumatoid Arthritis

KW - Linked data

KW - Mortality

KW - comorbidity

KW - Biological therapy

KW - Hospital admissions

KW - burden

U2 - 10.26182/ffr0-m264

DO - 10.26182/ffr0-m264

M3 - Doctoral Thesis

ER -

Determining the clinical epidemiology profile of Rheumatoid Arthritis and cost burden of hospital care in Western Australia (1980- 2015)

Abstract

Access to Document

Fingerprint

Cite this